Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 2
4(100.0%)
4Total
Phase 2(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06596434Phase 2Recruiting

4-Aminopyridine to Treat Skin Burns

Role: lead

NCT06294821Phase 2Not Yet Recruiting

4AP for Carpal Tunnel Syndrome (CTS)

Role: lead

NCT03701581Phase 2Recruiting

4-aminopyridine Treatment for Nerve Injury

Role: lead

NCT06333171Phase 2Recruiting

4-aminopyridine for Skin Wound Healing

Role: lead

All 4 trials loaded